or disease in service in these particular cases).

Available service treatment records (STRs) show that, when examined in May 1993, the Veteran's cholesterol was 261, that was considered high.  Laboratory tests performed in March and May 1994 reveal that his cholesterol was 296 and 301, respectively.   Results of laboratory tests performed in July 1994 at Darnall Army Community Hospital at Fort Hood, Texas (Darnall ACH), reflect the Veteran's increased glucose (114) and cholesterol (292) levels.  When examined for retirement in April 1998, his cholesterol was 312 and his HDL was 9.8.  Hyperlipidemia was noted.  It was also indicated that the Veteran was being tried on Mevacor and would be re-evaluated in two months.  Notably, however, the Veteran's April 1998 retirement examination didVeteran's statement that he was put on Glucophage temporarily secondary to his sugars starting to run high as a new way to prevent diabetes mellitus; he only had to take it for two months.  A November 12, 2007 private treatment record from W.S.M., III, D.O., indicated that the Veteran had a past medical history of non-insulin dependent diabetes mellitus.

In his December 2008 claim, the Veteran reported that he was diagnosed with diabetes mellitus, type II, on December 4, 2008; however, he stated, "I have been taking Glucophage for multiple years."

The Veteran was afforded a VA examination in May 2010, at which time, a VA physician reviewed the Veteran's medical records and said the Veteran was prescribed metformin due to a diagnosis of "pre" diabetes and to decrease